Back to search

Article

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study

2025-06-30

Abstract excerpt

<title>Abstract</title> <p> Variants in cytochrome P450 enzymes are known risk factors for developing adverse drug reactions (ADR). Most antidepressants (AD) are simultaneously metabolized by major or minor pathway of CYP2C19 and CYP2D6, resulting in a complex interplay of metabolites. This study is one of the first to investigate and demonstrate the combined CYP 2C19/2D6 functional metabolic status as a risk fa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc0acad2-ba4a-5ad3-a2a6-2ff4ffb3ef1d
DOI
10.21203/rs.3.rs-6406316/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort studyDOI 10.21203/rs.3.rs-6406316/v1
Select a neighboring publication to make it the new centre.